Search - tctmd.com

Displaying 401 - 420 of 476

Sort: Relevancy | Date

News Daily News

FDA: Global Recall of Cook Medical Central Venous Catheters and Pressure Monitoring Sets, Trays

L.A. McKeown

February 10, 2016

News Daily News

血压低于 140 毫米汞柱时卒中减少，进一步支持指南采用更低阈值

Michael O'Riordan

February 02, 2016

News Daily News

Reductions in Stroke Observed With BP Less Than 140 mm Hg, Fueling Support for Lower Threshold

Michael O'Riordan

February 02, 2016

News Daily News

Menos ACV con Presiones Arteriales Menor que 140 mm Hg Animan a Rebajar los Umbrales

Michael O'Riordan

February 02, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2016

Shelley Wood

February 01, 2016

News Daily News

Bradycardia Linked to Adverse Outcomes, But Only in Conjunction With Heart Rate-Modifying Drugs

Yael L. Maxwell

January 25, 2016

News Industry News

Vascular Dynamics’ MobiusHD™ System Receives CE Mark for the Treatment of Resistant Hypertension

January 05, 2016

News Daily News

无论基线血压和疾病史如何，降低血压均能减少血管风险

Michael O'Riordan

December 27, 2015

News Daily News

BP Lowering Reduces Vascular Risk Regardless of Baseline BP and Disease History

Michael O'Riordan

December 27, 2015

News Daily News

Bajar la Presión Arterial Reduce el Riesgo Vascular con Independencia de la Presión Arterial Basal y los Antecedentes Patológicos

Michael O'Riordan

December 27, 2015

News Industry News

Study Demonstrates i-cor® Synchronized Cardiac Assist Preserves Left Ventricular (LV) Function Compared to Continuous-Flow ECLS in Cardiogenic Shock

December 15, 2015

News Daily News

AHA Scientific Statement Highlights Sex Disparities in CV Risk Among Diabetic Patients

L.A. McKeown

December 09, 2015

News Conference News AHA 2015

SPRINT Makes Case for Even Lower BP Target in Many Hypertensive Patients

Todd Neale

November 08, 2015

News Conference News AHA 2015

AHA 2015 Promises Appropriate PCI, Ticagrelor Tolerance, Outcomes With IVUS, and More

Shelley Wood

November 05, 2015

News Daily News

Hemodynamic Depression Tied to Kidney Injury After CAS in Patients With Renal Disease

L.A. McKeown

September 28, 2015

News Industry News

Jardiance® (empagliflozin) is the only diabetes medication to show a significant reduction in both cardiovascular risk and cardiovascular death in a dedicated outcome trial

September 18, 2015

News Conference News ESC 2015

ESC Congress 2015: Presentations Sift Clinical Wheat From Chaff

September 09, 2015

News Daily News

COURAGE Analysis: Patients With Lower Exercise Capacity No More Likely to Benefit from Revascularization

L.A. McKeown

September 09, 2015

News Conference News ESC 2015

FREEDOM Substudy: CABG, PCI Outcomes Affected by Baseline BP

Yael L. Maxwell

August 30, 2015

News Industry News

Researchers Use Quanterix’s Simoa Technology to Detect Early Indicators of Potential Adverse Cardiovascular Outcomes

August 26, 2015

Advertisement

FDA: Global Recall of Cook Medical Central Venous Catheters and Pressure Monitoring Sets, Trays

血压低于 140 毫米汞柱时卒中减少，进一步支持指南采用更低阈值

Reductions in Stroke Observed With BP Less Than 140 mm Hg, Fueling Support for Lower Threshold

Menos ACV con Presiones Arteriales Menor que 140 mm Hg Animan a Rebajar los Umbrales

TCTMD’s Top 10 Most Popular Stories for January 2016

Bradycardia Linked to Adverse Outcomes, But Only in Conjunction With Heart Rate-Modifying Drugs

Vascular Dynamics’ MobiusHD™ System Receives CE Mark for the Treatment of Resistant Hypertension

无论基线血压和疾病史如何，降低血压均能减少血管风险

BP Lowering Reduces Vascular Risk Regardless of Baseline BP and Disease History

Bajar la Presión Arterial Reduce el Riesgo Vascular con Independencia de la Presión Arterial Basal y los Antecedentes Patológicos

Study Demonstrates i-cor® Synchronized Cardiac Assist Preserves Left Ventricular (LV) Function Compared to Continuous-Flow ECLS in Cardiogenic Shock

AHA Scientific Statement Highlights Sex Disparities in CV Risk Among Diabetic Patients

SPRINT Makes Case for Even Lower BP Target in Many Hypertensive Patients

AHA 2015 Promises Appropriate PCI, Ticagrelor Tolerance, Outcomes With IVUS, and More

Hemodynamic Depression Tied to Kidney Injury After CAS in Patients With Renal Disease

Jardiance® (empagliflozin) is the only diabetes medication to show a significant reduction in both cardiovascular risk and cardiovascular death in a dedicated outcome trial

ESC Congress 2015: Presentations Sift Clinical Wheat From Chaff

COURAGE Analysis: Patients With Lower Exercise Capacity No More Likely to Benefit from Revascularization

FREEDOM Substudy: CABG, PCI Outcomes Affected by Baseline BP

Researchers Use Quanterix’s Simoa Technology to Detect Early Indicators of Potential Adverse Cardiovascular Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content